Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.
Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.
复制标题
西曲瑞克(一种黄体生成素释放激素拮抗剂)在铂类耐药卵巢癌患者中的 II 期研究。
DOI:
10.1016/s0090-8258(03)00408-6
复制
发表时间:
2003
影响因子:
4.7
通讯作者:
Emons,Günter
中科院分区:
文献类型:
--
作者:
Verschraegen,ClaireF;Westphalen,Silke;Hu,Wei;Loyer,Evelyne;Kudelka,Andrzej;Völker,Peter;Kavanagh,John;Steger,Melissa;Schulz,Klaus-Dieter;Emons,Günter